Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 406 followers

Latest posts

Last updated about 2 hours ago

CMI Media Group bridges gaps in pharma marketing tech with newly launched Ad Astra platform

about 2 hours ago

CMI Media Group's Ad Astra platform looks to connect siloed pharma marketing...

Rising Stars: How Novo Nordisk’s Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer

about 2 hours ago

Tara Sparks was just days away from starting her new job at...

Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort

about 3 hours ago

As Amgen’s rare disease medicine Tavneos comes under intensifying pressure from the...

After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL

about 3 hours ago

Despite a recent failure as a second-line monotherapy in diffuse B-cell lymphoma...

FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program

about 4 hours ago

Eli Lilly, Regeneron and Fujifilm are among the seven companies that have...

Unicycive turned away by FDA again over manufacturer’s plant shortfalls

about 5 hours ago

Unicycive is optimistic the third-party manufacturing facility can meet FDA standards to...

Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months

about 8 hours ago

Klick Health has struck its third takeover in 18 months, snapping up...

BeOne’s Brukinsa hits goal in mantle cell lymphoma confirmatory trial

about 8 hours ago

A Brukinsa regimen has delivered a large progression-free survival benefit in what...

Zymeworks acquires struggling Theravance for $929M

1 day ago

Four months after Theravance Biopharma shut down its R&D unit, laid off...

FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster

1 day ago

Sobi’s plan to introduce a challenger to Amgen’s blockbuster gout drug Krystexxa...

Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa

1 day ago

The FDA has approved Viridian Therapeutics’ thyroid eye disease treatment Lumvoa, initiating...

FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483

4 days ago

The agency spotted seven observations at Dr. Reddy's Bachupally, Hyderabad, biologics plant...